| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-12 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-06 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |